Lexeo Therapeutics announced updates to key components of an Accelerated Approval pathway for LX2006 in Friedreich ataxia (FA) cardiomyopathy and new interim clinical data from their ongoing Phase I/II studies. Read their letter to the FA community at Pharma News - National Ataxia Foundation.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Trials of LX2006 for the treatment of Friedreichs Ataxia Cardiomyopathy | 0 | 149 | June 19, 2023 | |
| Friedreich's Ataxia Symposium at The Children's Hospital of Philadelphia | 0 | 1848 | January 12, 2015 | |
| Research and Markets: Friedreich Ataxia - Pipeline Review, H2 2012 | 0 | 1681 | August 13, 2013 | |
| USF Ataxia Research Center Leads Clinical Trial of Possible Friedreich's Drug | 2 | 1698 | August 24, 2013 | |
| Friedreich’s Ataxia: A Collaboration And Gene Therapy | 6 | 2085 | January 5, 2014 |